Contact information Group leaders Else Marit Løberg / Jon Lømo Department of Pathology, Tel: +47 22 11 89 13 E-mail: else.marit.loberg@ous-hf.no / Jon.lomo@ous-hf.no
Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA(2024) Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial J Immunother Cancer, 12(1) DOI 10.1136/jitc-2023-007990, PubMed 38242720
Eide NA, Faber RT, Garred Ø, Sørum Falk R, Robsahm TE(2024) Characterizations of uveal melanoma patients with three additional primary malignancies Acta Ophthalmol(in press) DOI 10.1111/aos.16631, PubMed 38229427
Navaratnam J, Faber R, Eide N, Lund-Iversen M, Garred Ø, Munier FL(2023) Retinocytoma Undergoing Retinoblastoma Transformation in an Adult Patient Case Rep Ophthalmol Med, 2023, 8127245 DOI 10.1155/2023/8127245, PubMed 37529687